Anand Rayons Limited Overview
| Field | Detail | Source |
|---|---|---|
| Legal name | Anand Rayons Limited | BSE filings; MCA |
| Former names / predecessor | M/s Anand Enterprise (partnership firm, est. 1 July 1987); converted to public limited company 20 September 2018 | IIFL company summary (from DRHP) |
| Founding year | 1987 (partnership); incorporated as company 2018 | DRHP via IIFL; Simply Wall St |
| Certificate of Incorporation | 2 October 2018 (conversion effective 20 September 2018) | DRHP via IIFL |
| CIN | L51909GJ2018PLC104200 | RegisterKaro (MCA data) |
| Incorporation jurisdiction | Gujarat, India; Registrar of Companies, Ahmedabad | RegisterKaro |
| Registered office / HQ | 305-306, Jay Sagar Complex, Opp. Sub Jail, Surat, Gujarat 395002, India | Simply Wall St; BSE filings |
| Exchange / ticker | BSE Limited — Scrip 542721, Symbol ARL (not listed on NSE) | BSE; MarketsMojo |
| Listing date | July 2019 (IPO allotment 2 July 2019) | Simply Wall St; MarketsMojo capital history |
| ISIN | INE02GA01012 | MarketsMojo; FinancialFilings |
| LEI | 335800FAGKR4XYASNE09 | FinancialFilings |
| CUSIP | Not applicable (no US listing) | — |
| Face value | ₹10 per share | Screener |
| Shares outstanding | ≈2.19 crore (derived: market cap ₹76.7 Cr ÷ price ₹35.0, Oct 2026); 2.147 crore reported Feb 2026 prior to July 2026 warrant conversion | Screener; Simply Wall St |
| Fiscal year end | 31 March | Annual reports |
| Employees | Not publicly disclosed in sources reviewed (Screener's extracted employee count is paywalled; not stated in aggregator data) | — |
| Statutory auditor | M/s M. R. Bombaywala & Co., Chartered Accountants (unmodified opinion on FY2026 results) | FY2026 results (BSE, 22 May 2026) |
| Internal auditor | M/s Sutarwala & Associates, Chartered Accountants, Surat (re-appointed for FY2027) | FY2026 board outcome |
| Company Secretary & Compliance Officer | Mrs. Varsha Maheshwari | BSE filings (2023–2026) |
| Market capitalisation (current) | ≈₹76.7 Cr at ₹35.0 (15 Oct 2026) | Screener |
| Website | www.anandrayons.com | Company |
| Industry classification | Consumer Discretionary › Textiles › Textiles & Apparels › Trading – Textile Products; NIC 51909 (wholesale trade) | Screener; RegisterKaro |
The listing details supplied (Country: India; Exchange: BSE; Ticker: ARL.BO) correspond to Anand Rayons Limited, BSE scrip code 542721, BSE trading symbol ARL, Reuters RIC ANAY.BO. The entity has not changed its name since conversion to a company in 2018 and remains listed on BSE.
Anand Rayons Limited is a Surat-based, promoter-controlled trader and distributor of synthetic and value-added yarns — principally polyester, nylon, viscose, embroidery and dyed yarns, and zari/core yarns — serving weavers, embroiderers, zari manufacturers and garment converters concentrated in Gujarat's synthetic-textile cluster and other Indian textile hubs. Operating since 1987 as a dealership-led wholesaler that historically represented mills such as JCT, Indorama Synthetics, Garden Silk and Filatex (Philatex), the company runs an asset-light, working-capital-intensive model with gross margins near 4% and operating margins of roughly 2–2.5%. FY2026 revenue reached a record ₹433 Cr with net profit of ₹7.25 Cr, funded in part by a ₹54 Cr preferential-warrant equity raise that de-levered the balance sheet. Management has signalled diversification into petrochemical oils, aluminium-foil packaging and food, but the business remains effectively a single-segment domestic textile trading house. Its equity has fallen ~92% from its ₹470 peak despite rising earnings.
What the company does
Anand Rayons is a trading and distribution business in man-made fibre (MMF) yarns. It purchases yarn in bulk from spinning/polymerisation mills (historically as an authorised dealer) and resells to downstream textile units — weavers producing sarees, shirting and dress material; embroidery units; yarn dyers; zari (metallic thread) manufacturers; carpet makers; narrow-fabric/elastic-tape producers; and sizing units. The company's own historical description (from its 2019 DRHP, as summarised by IIFL) emphasises trading in value-added yarns such as doped-dyed yarns and fancy yarns, a strong market share in embroidery and dyed yarn locally, and the supply of core yarn in value-added form to zari manufacturers.
The company's filings classify it in a single reportable segment — textiles/trading. The Q1 FY2026 results described the trading division as constituting the entirety of operations (ScanX digest of BSE filing, August 2025), and the Q2 FY2026 results reiterated that the company operates solely in the textile segment.
Company's own characterisation (latest available)
The company's annual-report business overview (FY2024 report, as extracted by Screener) describes Anand Rayons as part of the "Anand Group", specialising in embroidery yarn, dyed yarn, and fabric manufacturing for T-shirts, garments and apparel. The same report states the company had diversified into petrochemical products — yellow oil, white oil, base oil and palm oil, primarily for adhesive industries — planned to export chemicals internationally, and had ventured into packaging by importing aluminium foil and other packaging products. Screener's corporate summary describes the business as "manufacturing and trading of yarn & fabrics", though no manufacturing fixed assets of consequence appear on the balance sheet (fixed assets ≈₹1 Cr at March 2026), which suggests any "manufacturing" is outsourced/job-work based.
Business model and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Product vs. service mix | ~100% product sales (traded goods); no disclosed service, subscription or licensing revenue | Single trading segment in results |
| Value-chain position | Mid-stream intermediary between yarn producers (polymer/spinning mills) and fragmented downstream weaving/embroidery/zari units | DRHP history; AR FY2024 |
| Gross margin | ≈4.7% (Simply Wall St TTM gross profit ₹18.8 Cr on revenue ₹401 Cr, data to Dec 2025) | Simply Wall St |
| Operating margin (OPM) | 1.4%–2.5% range across FY2020–FY2026 | Screener |
| Capital intensity | Very low fixed assets (≈₹1 Cr); balance sheet is >95% current assets (receivables, inventory, cash) | Screener balance sheet |
| Working-capital profile | Debtor days 73, inventory days 7, payable days 3 → cash conversion cycle 77 days (FY2026) | Screener ratios |
| Credit role | Effectively extends trade credit to small downstream units while paying suppliers quickly — a financing function embedded in the trading margin | Debtor vs payable days |
| Customer types | MSME weavers, embroiderers, zari makers, yarn dyers, carpet and elastic-tape makers, sizing units | DRHP via IIFL |
| End-markets | Domestic Indian apparel, ethnic wear (sarees, dress material), home textiles (carpets), narrow fabrics | DRHP via IIFL; Zonebourse description |
| Geography | Domestic India only; historically Surat, later Ahmedabad, Vapi, Daman, Varanasi, Ichalkaranji, Bengaluru, Erode, Coimbatore | DRHP via IIFL |
Independent characterisation
In substance, Anand Rayons is a thin-margin, high-turnover working-capital business whose economic value derives from (a) supplier relationships and dealership access in a commoditised market, (b) credit underwriting of small textile units, and (c) inventory/price-risk management in yarns whose prices track crude-oil-linked feedstocks (PTA, MEG, caprolactam). Return on equity has historically been modest (5-year average ≈8% per Screener) because each rupee of profit requires substantial receivables financing. The FY2025–FY2026 preferential equity raise transformed the balance sheet from a 1:1 debt-to-equity structure to ~0.35x and enabled the 38% revenue jump in FY2026, but it also diluted ROE. The announced diversification initiatives (petrochemical oils, aluminium foil, food partnership) have not been reported as separate segments, and their revenue contribution is not publicly disclosed.
Strategy
Stated corporate strategy
Anand Rayons does not publish an investor presentation, hold earnings calls or host investor days, so strategy must be inferred from annual-report narrative and exchange disclosures. Themes discernible from the FY2024 annual report and subsequent filings:
-
Core franchise in value-added yarns — maintaining position in embroidery, dyed and zari-core yarns where the company claims local market share.
-
Adjacent-commodity diversification — trading petrochemical oils (yellow, white, base, palm oil) for adhesive makers, leveraging the same B2B trading competence.
-
International expansion — stated plan to export chemicals.
-
Packaging — import and distribution of aluminium foil and packaging products.
-
Food sector entry — five-year partnership with Chhabee Nutricos Inds LLP (announced August 2025), framed by the company as a response to growth opportunities and rising consumer demand in food and beverages, and as a means of reducing dependence on a single sector.
-
Balance-sheet strengthening — the ₹69 Cr (potential) preferential warrant programme approved January 2025 to fund working capital and growth.
Strategic initiatives register (last 24 months)
| Date | Initiative | Type | Status / outcome |
|---|---|---|---|
| 8 Jan 2025 | Shareholder approval for preferential warrant issue | Capital raise | Approved |
| 19 Feb 2025 | Allotment of 88.62 lakh warrants at ₹78 | Capital raise | ≈78% converted; 19.38 lakh lapsed 28 Sep 2026 |
| Feb 2025 – Jul 2026 | Successive warrant conversions (22 Feb 2025, 24 May 2025, 9 Jun 2025, 23 Jul 2025, 17 Jan 2026, 20 Jul 2026) | Capital raise | ≈₹54 Cr received (derived) |
| Aug 2025 | Chhabee Nutricos Inds LLP partnership (food) | New business | Revenue contribution not disclosed; no separate segment |
| 31 Aug 2026 | ₹10 Cr increase in authorised capital | Capital structure | Signals potential future equity issuance; purpose not disclosed |
| FY2024 onward | Petrochemical oils and aluminium-foil trading | Diversification | Revenue contribution not disclosed |
Cost programmes, ESG commitments and medium-term targets
Cost programmes: none announced. The Q3 FY2026 digest refers generically to cost management yielding results, without quantification.
ESG/sustainability commitments: none disclosed.
Medium-term financial targets / guidance: not publicly disclosed. Management provides no revenue, margin or return guidance.
Products & Services
All products sit within the single textile/trading segment. The company does not publish SKU-level specifications, launch years or pricing; it trades third-party mill brands. Pricing is market-linked (spot/contract yarn prices) and not publicly disclosed.
Flagship offerings: No proprietary brands are disclosed. The commercially significant lines, based on management's own historical emphasis, are embroidery yarn, dyed yarn, and core yarn for zari.
Product Portfolio
| # | Product line | Description & key specifications | Target customer | Origin / year | Pricing model |
|---|---|---|---|---|---|
| 1 | Polyester yarn | Synthetic filament yarn based on PET (from PTA and MEG); traded forms per industry norms include POY, FDY and DTY | Weavers (sarees, shirting, dress material), knitters | Core line since dealership era (Indorama Synthetics, Garden Silk, Filatex) | Market-linked; not disclosed |
| 2 | Nylon yarn | Available as nylon POY, FDY, DTY and dyed nylon yarn; applications include fabrics, bridal veils, carpets, ropes | Weavers, carpet makers, technical/narrow-fabric units | Dealership of JCT Limited historically | Market-linked; not disclosed |
| 3 | Embroidery yarn | Value-added filament yarn for machine embroidery; company claims a "decent market share" locally | Surat embroidery units | Long-standing line | — |
| 4 | Dyed yarn / doped-dyed yarn | Pre-coloured yarns (dope-dyed at polymer stage or package-dyed) | Weavers, embroiderers seeking colour-fast yarn | Long-standing value-added line | — |
| 5 | Zari / core yarn | Core yarn supplied in value-added form to zari (metallic thread) manufacturers; zari itself also traded | Zari manufacturers (Surat is a major zari centre) | Long-standing | — |
| 6 | Viscose (rayon) yarn | Cellulosic yarn (the company's name derives from rayon) | Weavers of ethnic wear and dress material | Long-standing | — |
| 7 | Fancy yarns | Novelty/effect yarns for sarees, dress materials | Weavers | Value-added line | — |
| 8 | Yarns for elastic tapes & sizing | Yarns for narrow fabrics and sizing segment | Elastic-tape makers, sizing units | Value-added line | — |
| 9 | Carpet yarns | Yarns for carpet manufacturing | Carpet makers | Value-added line | — |
| 10 | Fabrics (T-shirt/apparel) | Fabric "manufacturing" for T-shirts, garments, apparel (likely via job-work given negligible fixed assets) | Garment makers | Disclosed in AR FY2024 | — |
| 11 | Petrochemical oils | Yellow oil, white oil, base oil, palm oil — primarily for adhesive industries | Adhesive manufacturers | Disclosed in AR FY2024 | — |
| 12 | Chemicals (export) | Plan to export chemicals internationally | Overseas buyers | Planned (AR FY2024); no export revenue disclosed | — |
| 13 | Aluminium foil & packaging | Imported aluminium foil and other packaging products | Packaging users | Disclosed in AR FY2024 | — |
| 14 | Food products (via partnership) | Food-sector business with Chhabee Nutricos Inds LLP (5-year arrangement) | Food & beverage market | Announced Aug 2025 | — |
“—” = not publicly disclosed.
Financial Narrative
Income statement (FY2022–FY2026), ₹ Cr unless stated
Source: Screener (C-MOTS data from BSE filings); FY2024–FY2026 line items aggregated from quarterly BSE results; FY2026 PBT/PAT from company-reported audited results (22 May 2026). FY2022–FY2023 figures are rounded to the nearest crore in the source and are reconstructed from margins/EPS where stated.
Notes:
-
Gross profit is not separately reported in quarterly formats; Simply Wall St (S&P data) shows TTM gross profit of ₹18.8 Cr on revenue of ₹401 Cr for the twelve months to December 2025 (gross margin ≈4.7%). Annual gross profit by year is not publicly disclosed in the sources reviewed.
-
EBITDA here equals operating profit before other income (Screener definition). EBITDA including other income for FY2026 = ₹12.39 Cr.
-
FY2022 and FY2023 net profit derived as EPS × 1.498 Cr shares (shares outstanding in those years).
-
Screener lists FY2026 EPS as ₹3.38; the company-reported basic EPS is ₹3.36. The difference reflects weighted-share computation; company figure preferred.
Revenue CAGR FY2022–FY2026: ≈6.7%: (derived: (432.96/334)^(1/4) − 1). Screener's 5-year sales CAGR (to TTM) is 16% because FY2021 (₹207 Cr, COVID trough) is the base.
Net profit CAGR FY2022–FY2026: ≈25.3%: (derived: (7.25/2.94)^(1/4) − 1).
Commentary — income statement. The five-year record divides into two regimes. From FY2022 to FY2025, revenue was essentially flat at ₹314–344 Cr and net profit stuck at ₹2.9–3.5 Cr, with margins pinned in a 2.1–2.4% operating band — the signature of a commoditised trading book constrained by balance-sheet capacity (borrowings of ₹29–34 Cr against net worth of ₹30–36 Cr). FY2025 saw an 8.9% revenue decline, consistent with weak synthetic-textile demand and yarn-price deflation that year, yet net profit still edged up 11% due to better gross realisation (OPM 2.4%) and lower interest cost.
FY2026 marks a clear inflection: revenue jumped 38% to a record ₹433 Cr and net profit more than doubled to ₹7.25 Cr. Three drivers are visible in the numbers. First, balance-sheet capacity: warrant-conversion proceeds raised net worth from ₹36 Cr (March 2024) to ₹102 Cr (March 2026), allowing a larger receivables book. Second, other income rose from ₹0.10 Cr to ₹2.37 Cr — likely treasury income on cash parked from equity raises — contributing roughly a quarter of FY2026 pre-tax profit. Third, lower finance cost (₹2.31 Cr vs ₹2.65 Cr) despite a much larger revenue base. Core operating margin did not expand (2.31% vs 2.40%), meaning the profit surge was volume- and financing-driven rather than a structural margin improvement.
Quarterly income statement (Q1 FY2025 – Q1 FY2027), ₹ Cr
Source: Screener (BSE quarterly results). Quarterly results show 0% tax; the company books income tax at the year-end, so quarterly "net profit" equals pre-tax profit.
Commentary — quarterly. Five consecutive quarters of positive YoY revenue growth (Q1 FY2026–Q1 FY2027) have followed four quarters of decline. Q3 FY2026 was exceptional (OPM 3.81%, PBT ₹4.50 Cr — 46% of full-year FY2026 PBT in one quarter), which raises the question of whether a one-off trade or inventory gain inflated the quarter; no explanation is publicly disclosed. Q2 FY2026's EBITDA margin compressed to 1.22% from 2.44% a year earlier (ScanX digest), showing that the volume ramp initially came at lower unit margins. Q1 FY2027 (revenue ₹95.6 Cr, PBT ₹2.32 Cr) shows growth continuing but decelerating to 26% YoY and a sequential revenue decline of 19% from Q4 FY2026.
Analytical warning on TTM P/E. Aggregators compute TTM net profit of ≈₹10.9 Cr by summing quarterly figures that are in fact pre-tax. Applying the FY2026 effective rate (25.5%) gives normalised TTM PAT of ≈₹8.1 Cr (derived). Reported TTM P/E of ~7x therefore understates the true multiple; on normalised earnings it is ≈9.5x.
Balance sheet (31 March), ₹ Cr
Source: Screener (BSE annual reports). Rounded to nearest crore in source.
Additional data points:
Net debt, March 2026: ₹1.95 Cr: (Zerodha/aggregator), implying cash and equivalents of roughly ₹34 Cr against ₹36 Cr of borrowings. This is consistent with cumulative positive net cash flows of ₹5 Cr, ₹10 Cr, ₹9 Cr and ₹10 Cr in FY2023–FY2026 (Screener). Cash balances for earlier years are not separately extracted in sources reviewed.
Short- vs long-term debt split: not publicly disclosed in sources reviewed; given the trading model and absence of fixed assets, borrowings are presumed predominantly working-capital (short-term) facilities. RegisterKaro reports no open MCA-registered charges, which is unusual for bank working-capital lines and warrants verification against the FY2026 annual report.
Half-year balance sheet (30 Sep 2025): total assets ₹150.48 Cr; shareholders' funds ₹96.62 Cr; current assets ₹147.09 Cr (vs ₹96.58 Cr at March 2025) (ScanX digest of BSE filing).
FY2026 per FinancialFilings: total assets INR 1.53 billion; total equity INR 1.02 billion; cash from operations INR −112.81 million — consistent with Screener.
Working capital: current assets ≈₹150 Cr less current liabilities (other liabilities ₹15 Cr plus short-term borrowings of up to ₹36 Cr) implies net working capital of roughly ₹100 Cr at March 2026 (derived; exact current-liability split not disclosed in sources reviewed).
Book value per share: ₹47.6 (Screener, latest).
Commentary — balance sheet. Total assets doubled from ₹74 Cr to ₹153 Cr in two years, funded almost entirely by equity (net worth +₹66 Cr) rather than debt. The equity build reconciles closely with warrant economics: ≈69.24 lakh warrants converted at ₹78 (≈₹54 Cr, derived from 88.62 lakh allotted less 19.38 lakh lapsed), plus retained earnings of ≈₹10.7 Cr over FY2025–FY2026, plus the ₹3.78 Cr forfeiture credited after the September 2026 lapse (post-period). Borrowings dipped to ₹16 Cr in FY2025 as early conversion money repaid debt, then rose back to ₹36 Cr in FY2026 as the business scaled. The balance sheet is now conservatively geared, but its quality depends almost entirely on the collectability of trade receivables (73 debtor days on ₹433 Cr revenue ≈ ₹87 Cr of receivables — derived).
Cash flow statement, ₹ Cr
Source: Screener.
Commentary — cash flow. FY2022–FY2025 showed strong cash conversion (CFO exceeding EBITDA) as the company harvested working capital. FY2026 reversed sharply: operating cash flow of −₹11 Cr despite record profit, because receivables and other current assets absorbed the growth. The investing outflows of ₹24 Cr (FY2025) and ₹14 Cr (FY2026) are large relative to capex of ₹1–3 Cr; they most likely reflect deployment of equity proceeds into deposits/treasury instruments (consistent with rising other income), though the breakdown is not disclosed in sources reviewed. Financing inflows of ₹22 Cr and ₹36 Cr reflect warrant conversions and, in FY2026, a re-increase in borrowings. The business has never bought back shares and has paid a dividend only once (FY2019).
Ratio analysis
Source: Screener for ROCE and working-capital days; other ratios derived from the tables above (average-balance basis where noted).
Additional ratios:
Net debt / EBITDA (FY2026): ≈0.2x (₹1.95 Cr ÷ ₹10.02 Cr; derived).
ROIC: not separately computed by sources; given negligible fixed assets, ROIC approximates ROCE (≈10% FY2026).
Current ratio: not publicly disclosed in sources reviewed; with current assets ≈₹150 Cr and total non-equity liabilities ≈₹51 Cr, the current ratio is at least ~2.9x (derived upper-bound proxy).
Commentary — ratios. Return metrics are structurally capped by the trading model: ROE around 8–10% with a sub-1% net margin offset by 3.4–4.6x asset turnover. The FY2025 ROE trough (6.2%) is a dilution artefact — equity doubled before the incremental capital could be deployed. Interest coverage has improved markedly (5.2x), and leverage is now low. The most important adverse trend is in working capital: debtor days have risen from 44 (FY2024) to 73 (FY2026), and payable days have fallen to just 3, meaning Anand Rayons is financing both its customers and, effectively, prepaying suppliers. This is the mechanism by which the FY2026 growth consumed cash, and it is the key credit risk to monitor.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 334 | 336 | 344.26 | 313.75 | 432.96 |
Revenue YoY growth (%) | 61.4 | 0.6 | 2.5 | -8.9 | 38.0 |
Operating profit / EBITDA excl. other income (INR Cr) | 8.0 | 7.1 | 7.27 | 7.53 | 10.02 |
Other income (INR Cr) | 0 | 0 | 0.07 | 0.10 | 2.37 |
Interest expense (INR Cr) | 4 | 3 | 2.88 | 2.65 | 2.31 |
Depreciation (INR Cr) | 0 | 0 | 0.22 | 0.32 | 0.36 |
Profit before tax (INR Cr) | 4 | 4 | 4.24 | 4.65 | 9.73 |
Tax rate (%) | 29 | 26 | 26 | 25 | 25 |
Net profit (INR Cr) | 2.94 | 3.15 | 3.13 | 3.47 | 7.25 |
EPS basic (INR) | 1.96 | 2.10 | 2.09 | 1.89 | 3.36 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Operating (EBITDA) margin (%) | 2.4 | 2.1 | 2.1 | 2.4 | 2.3 |
Pre-tax margin (%) | 1.2 | 1.2 | 1.2 | 1.5 | 2.2 |
Net margin (%) | 0.88 | 0.94 | 0.91 | 1.11 | 1.67 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (Quarterly)
| Metric | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 70.31 | 82.95 | 74.64 | 85.85 | 75.95 | 112.25 | 126.66 | 118.10 | 95.58 |
Revenue YoY (%) | -5.7 | -1.9 | -17.6 | -9.2 | 8.0 | 35.3 | 69.7 | 37.6 | 25.8 |
Operating profit (INR Cr) | 0.92 | 2.02 | 1.75 | 2.84 | 1.13 | 1.35 | 4.82 | 2.72 | 2.25 |
OPM (%) | 1.31 | 2.44 | 2.34 | 3.31 | 1.49 | 1.20 | 3.81 | 2.30 | 2.35 |
Other income (INR Cr) | 0.00 | 0.01 | 0.00 | 0.09 | 0.31 | 0.65 | 0.61 | 0.80 | 0.67 |
Interest (INR Cr) | 0.34 | 0.90 | 0.81 | 0.60 | 0.18 | 0.41 | 0.84 | 0.88 | 0.54 |
PBT (INR Cr) | 0.52 | 1.07 | 0.82 | 2.25 | 1.17 | 1.50 | 4.50 | 2.55 | 2.32 |
EPS (₹, pre-tax basis) | 0.35 | 0.71 | 0.54 | 1.22 | 0.56 | 0.70 | 2.11 | 1.19 | 1.08 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Equity share capital (INR Cr) | 15 | 15 | 15 | 18 | 21 |
Reserves (INR Cr) | 15 | 18 | 21 | 58 | 81 |
Total equity / net worth (INR Cr) | 30 | 33 | 36 | 76 | 102 |
Borrowings (INR Cr) | 31 | 34 | 29 | 16 | 36 |
Other liabilities (INR Cr) | 18 | 9 | 9 | 6 | 15 |
Total assets (INR Cr) | 79 | 76 | 74 | 99 | 153 |
Fixed assets (INR Cr) | 0 | 0 | 1 | 1 | 1 |
Capital work in progress (INR Cr) | 0 | 0 | 0 | 0 | 2 |
Goodwill & intangibles (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Other (mainly current) assets (INR Cr) | 79 | 76 | 73 | 98 | 150 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | 9 | 7 | 16 | 11 | -11 |
Cash from investing activities (INR Cr) | 0 | -2 | 2 | -24 | -14 |
Cash from financing activities (INR Cr) | -9 | 0 | -8 | 22 | 36 |
Net cash flow (INR Cr) | 0 | 5 | 10 | 9 | 10 |
Free cash flow (INR Cr) | 9 | 7 | 16 | 10 | -14 |
Capex (INR Cr, derived CFO − FCF) | 0 | 0 | 0 | 1 | 3 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO / EBITDA (%) | 123 | 117 | 239 | 165 | -88 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%, PAT / avg equity) | 10.3 | 10.0 | 9.1 | 6.2 | 8.1 |
ROA (%, PAT / avg assets) | 4.0 | 4.1 | 4.2 | 4.0 | 5.8 |
ROCE (%, Screener) | 13 | 11 | 11 | 9 | 10 |
Debt / equity (x) | 1.03 | 1.03 | 0.81 | 0.21 | 0.35 |
Interest coverage (EBIT / interest, x) | 2.0 | 2.3 | 2.5 | 2.8 | 5.2 |
Asset turnover (sales / avg assets, x) | 4.5 | 4.3 | 4.6 | 3.6 | 3.4 |
Debtor days | 67 | 58 | 44 | 57 | 73 |
Inventory days | 8 | 7 | 7 | 17 | 7 |
Payable days | 18 | 8 | 8 | 5 | 3 |
Cash conversion cycle (days) | 57 | 57 | 44 | 69 | 77 |
Working capital days | 40 | 38 | 26 | 64 | 54 |
Revenue by Region and Revenue by Region (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India revenue (INR Cr) | 344.26 | 313.75 | 432.96 |
Outside India revenue (INR Cr) | 0 | 0 | 0 |
India share of revenue (%) | 100 | 100 | 100 |
India revenue YoY growth (%) | 2.5 | -8.9 | 38.0 |
Share Price History
| Date | Price (INR) | Market cap (INR Cr) | Note |
|---|---|---|---|
Jul 2019 | ≈27 | ≈40 | IPO price (implied) |
7 Jan 2025 | 166.05 | — | Upper circuit; 52-week range ₹36.37–166.05 |
28 Mar 2025 | 200.50 | 299.77 | +299% over prior 6 months |
1 Aug 2025 | 294.20 | ≈620 | P/E ≈117x (Screener at the time) |
9 Sep 2025 | — | 794.13 | Choice India |
Late 2025 / Jan 2026 | 470.00 | — | All-time/52-week high (date unconfirmed) |
20 Jan 2026 | 388.00 | 828.10 | Choice India |
11 Feb 2026 | 208.25 | 470.62 | Upstox |
6 Mar 2026 | 91.95 | ≈197 | −62% in 1 month (Simply Wall St) |
2 Apr 2026 | 63.43 | ≈136 | ICICIdirect |
30 Apr 2026 | 57.73 | 124 | Value Research |
1 Jun 2026 | 47.72 | — | Value Research |
7 Aug 2026 | 42.71 | ≈91 | 5paisa |
2 Sep 2026 | 41.67 | — | Anand Rathi |
6 Oct 2026 | 33.00 | ≈72 | 52-week low (MarketsMojo) |
15 Oct 2026 | 35.00 | 76.7 | Screener |
Share Price & Returns
| Horizon | Return | Source |
|---|---|---|
1 year | ≈−92% | Screener; ScanX (−92.48%) |
3-year CAGR | ≈−5% | Screener |
5-year CAGR | ≈−22% | Screener |
Since IPO (≈₹27) | ≈+30% | Derived (₹35 vs ≈₹27) |
Valuation Multiples
| Multiple | Anand Rayons | Basis | Peer range (Value Research) |
|---|---|---|---|
P/E (reported TTM) | 7.05x | Screener, on pre-tax quarterly sum | 15.9x–91.2x |
P/E (normalised TTM) | ≈9.5x | Derived: ₹76.7 Cr ÷ (₹10.87 Cr × (1−0.255)) | — |
P/E (FY2026 reported PAT) | ≈10.6x | Derived: ₹76.7 Cr ÷ ₹7.25 Cr | — |
P/B | 0.74x | Screener (book value ₹47.6) | 2.1x–2.9x |
EV/EBITDA (TTM) | ≈7.2x | Derived: EV ≈₹78.7 Cr (mcap + net debt ₹1.95 Cr) ÷ TTM operating profit ₹11.14 Cr | — |
EV/Sales (TTM) | ≈0.17x | Derived: ₹78.7 Cr ÷ ₹453 Cr | — |
Dividend yield | 0% | Screener | — |
Dividend History
| Fiscal year | DPS (INR) | Payout (%) |
|---|---|---|
FY2019 | ≈0.50 (derived from 24% payout on EPS ₹2.08; paid Sep 2019) | 24 |
FY2020–FY2026 | 0 | 0 |
Capital Markets
| Item | Status |
|---|---|
Buyback authorisations | None ever |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Domestic bank-loan ratings (CRISIL / ICRA / CARE / India Ratings) | None identified in sources reviewed |
Listed debt / NCDs | None (Reg. 57(5) non-applicability confirmed 3 Apr 2026) |
Debt maturity profile | Not publicly disclosed; borrowings of ₹36 Cr (March 2026) presumed short-term working-capital lines |
Equity share-capital trajectory | ₹14.98 Cr (2019) → ≈₹21.9 Cr (2026, derived) via warrant conversions; authorised capital to increase by ₹10 Cr (approved by board 31 Aug 2026) |
Analyst Conclusions
Management guidance and consensus
Management guidance: none published.
Consensus estimates: none (zero coverage).
Run-rate indicator: H1-equivalent trailing data show revenue of ₹453 Cr TTM (to June 2026) and Q1 FY2027 growth of 26% YoY. If the company merely holds the TTM run-rate with FY2026 margins, FY2027 revenue would be ≈₹450–460 Cr and PAT ≈₹8 Cr (illustrative arithmetic, not a forecast).
Bull case (grounded in data)
-
Cheap on assets and earnings: P/B 0.74x against book value of ₹47.6, with ≈₹34 Cr of cash (implied) and near-zero net debt; normalised P/E ≈9.5x versus textile peers at 16–91x.
-
Demonstrated operating leverage from new capital: FY2026 revenue +38% and PAT +109%; Q3 FY2026 proved a ₹127 Cr quarterly revenue capacity at 3.8% OPM; five straight quarters of YoY growth.
-
Insider alignment improving: promoters bought shares on the open market in September–October 2026, lifting Anand Bakshi's stake to 27.47% and promoter group to 53.60%, while the warrant overhang has been extinguished (lapse of 19.38 lakh warrants).
Bear case (grounded in data)
-
Profit quality is weak: FY2026 CFO of −₹11 Cr; debtor days 73 and rising; ≈24% of FY2026 PBT came from other income rather than trading.
-
Structural return ceiling: OPM stuck at ~2–2.5% for six years; ROE ~8% even after doubling profit — below cost of equity for a micro-cap.
-
Disclosure and governance risk: BSE discrepancy notice and revised results (Aug 2025), revised FY2026 audited results, rescheduled results meeting, undisclosed economics of food/oil/foil diversification, combined Chair/MD, and an authorised-capital increase that could signal further dilution.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | By mid-Nov 2026 | Revenue vs ₹112.25 Cr base; OPM; sequential recovery from Q1 |
| H1 FY2027 balance sheet | Nov 2026 | Receivables, cash, borrowings; CFO direction |
| Use of ₹10 Cr authorised-capital headroom | Any time | Any new preferential issue, pricing, allottees |
| Food (Chhabee Nutricos) and petrochemical/foil revenue disclosure | FY2027 annual report (~Aug 2027) | Whether diversification is material or cosmetic |
| Q3 FY2027 results | Feb 2027 | Comparison against record Q3 FY2026 (₹4.50 Cr PBT) |
| FY2027 audited results | May 2027 | Full-year tax normalisation, CSR applicability, dividend decision |
| Promoter trading | Ongoing | Continued buying vs selling/pledging |
| Exchange surveillance status | Ongoing | ASM/GSM inclusion affecting liquidity |
Concluding analyst verdict
Anand Rayons is, at its core, a small and competent Surat yarn trader that has been temporarily mistaken by the market for something else — first for a high-growth diversification story worth more than ₹800 Cr, and now, perhaps, for a business whose numbers cannot be trusted at all. The truth, as best the public record allows, lies between. The operating facts are genuinely improved: FY2026 revenue of ₹433 Cr and net profit of ₹7.25 Cr are records; leverage has fallen from roughly 1x to 0.35x; and interest coverage exceeds 5x. These gains are, however, largely a function of fresh equity rather than a better business: operating margins remain at ~2.3%, return on equity sits near 8%, and growth consumed ₹11 Cr of operating cash as receivables ballooned.
At ₹35, the market capitalisation of roughly ₹77 Cr sits below book value and around 9–10x normalised earnings — a valuation that already discounts a no-growth, thin-margin trader. That makes the downside from here primarily a function of balance-sheet quality, specifically the collectability of ≈₹87 Cr of trade receivables, rather than of earnings multiples. The upside requires evidence that FY2026's volume gains are durable, that cash flow turns positive, and that management stops announcing unquantified diversifications.
Governance signals are mixed: promoter buying and the extinguished warrant overhang are constructive, but a BSE-flagged results discrepancy, revised filings, a rescheduled results meeting, and a newly expanded authorised capital argue for caution. With no analyst coverage, no guidance and no investor communication, information asymmetry is extreme.
Verdict: a speculative, deep-value special situation. The Q2 FY2027 balance sheet (cash flow and debtor days) is the single most important near-term datapoint; absent improvement there, the low multiple is justified.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | DIN | Tenure | Background / notes | Source |
|---|---|---|---|---|---|
Anand Gokulbhai Bakshi | Chairman & Managing Director; Promoter | 01,942,639 | CMD since 20 Sep 2018; partner in predecessor firm since 1992; re-appointed MD for 2 years (31 Aug 2026) | Founder-promoter; age ≈51–52 (Simply Wall St/MarketScreener) | BSE filings; Simply Wall St |
Shilpa Anand Bakshi | Whole-time Director; Promoter group | 07,986,896 | Director since 2018; re-appointed WTD for 2 years (31 Aug 2026) | Promoter-family member; only woman director identified | BSE filings |
Pankesh Patel | Non-Executive Independent Director | 09,494,163 | Appointed Additional ID 15 Feb 2022; re-appointed for second 5-year term (31 Aug 2026) | Background not disclosed in sources reviewed | BSE filing 15 Feb 2022; JKBFSL |
Anil Navinchandra Merchant | Non-Executive Independent Director | 09,414,010 | Appointed ~2021–22; re-appointed for second 5-year term (31 Aug 2026) | Background not disclosed in sources reviewed | BSE filings; JKBFSL |
Nileshkumar Mangaldas Bodiwala | Non-Executive Independent Director | 08,465,357 | Since 29 May 2019 (≈7 years) | Background not disclosed in sources reviewed | FY2019 AR; Blinkx |
Executive Leadership Team
| Name | Title | Tenure | Notes |
|---|---|---|---|
Anand Bakshi | CEO equivalent (CMD) | Since Sep 2018 | Total compensation ≈₹2.4 million (≈US$27k) per Simply Wall St (latest fiscal year available to that source); salary/bonus/stock split not disclosed in sources reviewed |
Varsha Maheshwari | Company Secretary & Compliance Officer | Since ~2021 (board considered CS appointment 5 May 2021; MarketScreener lists compliance officer since 5 May 2021, age 31) | Signs BSE filings |
CFO | Chief Financial Officer | Since 1 Oct 2018 (MarketScreener) | Name not confirmed in sources reviewed |
Governance Overview
| Attribute | Assessment |
|---|---|
Board size | 5 |
Independent directors | 3 of 5 (60%) |
Executive directors | 2 (both promoter family) |
Women directors | 1 (Shilpa Bakshi — executive, promoter group) |
Chair/CEO separation | No — combined Chairman & Managing Director |
Committees | Audit Committee, Nomination & Remuneration Committee, Stakeholders' Relationship Committee (statutory under Companies Act 2013/SEBI LODR); committee reconstitution disclosed Feb 2022 with Anand Bakshi as member of at least two committees. Current chairs not confirmed in sources reviewed |
Average board tenure | ≈5.1 years (Simply Wall St) |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
15 Feb 2022 | Pankesh Patel appointed Additional Independent Director; committees reconstituted after a director's resignation | BSE filing |
5 Aug 2025 | Appointment of secretarial auditor approved alongside Q1 FY2026 results | ScanX |
22 May 2026 | Internal auditor Sutarwala & Associates re-appointed for FY2027 | FY2026 results outcome |
31 Aug 2026 | Re-appointments: Anil Merchant and Pankesh Patel (IDs, second 5-year term); Anand Bakshi (MD, 2 years); Shilpa Bakshi (WTD, 2 years) | JKBFSL corporate news |
Shareholding Trend
| Holder category | Mar 2024 | Mar 2025 | Jun 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Promoters & promoter group (%) | 70.72 | 58.22 | 51.53 | 52.57 | 53.60 |
Public (%) | 29.28 | 41.78 | 48.46 | 47.43 | 46.41 |
FIIs (%) | 0 | 0 | 0 | 0 | 0 |
DIIs / mutual funds (%) | 0 | 0 | 0 | 0 | 0 |
Number of shareholders | 6,209 | 4,887 | 4,671 | 5,599 | 5,985 |
Major Shareholders
| Holder | Stake | As of | Source |
|---|---|---|---|
Anand Gokulbhai Bakshi (promoter) | 27.47% | 30 Sep 2026 (after open-market purchase of 10,377 shares for ₹3.64 lakh) | BSE PIT disclosure, 2 Oct 2026 |
Anand Gokulbhai Bakshi (earlier) | 26.64% (57,18,652 shares) | H1 CY2026 | Bajaj Finserv |
Shilpa Anand Bakshi (promoter group) | 5.96% (12,78,564 shares) | H1 CY2026 | Bajaj Finserv |
Anand Bakshi HUF (promoter group) | 0.58% (1,24,000 shares) | H1 CY2026 | Bajaj Finserv |
Other promoter-group members | ≈19–20% combined (individual names not confirmed in sources reviewed) | Sep 2026 (derived: 53.60% less named holdings) | Derived |
Institutional investors | None (0% FII, 0% DII) | Sep 2026 | Screener; Sharpely |
Competitive Landscape
Key Competitors
| # | Competitor | Category | Relevance | Comparative scale |
|---|---|---|---|---|
| 1 | Nitin Spinners Ltd | Listed yarn & fabric manufacturer | Value Research peer | Revenue ₹3,296 Cr |
| 2 | Sangam (India) Ltd | Listed yarn & fabric manufacturer (synthetic/blended yarn) | Value Research peer | Revenue ₹3,305 Cr |
| 3 | Ganesha Ecosphere Ltd | Listed recycled-polyester fibre/yarn maker | Value Research peer | Revenue ₹1,568 Cr |
| 4 | AYM Syntex Ltd | Listed polyester/nylon filament yarn maker | Value Research peer | Revenue ₹1,390 Cr |
| 5 | Amarjothi Spinning Mills Ltd | Listed spinner | Zerodha-named competitor | — |
| 6 | Filatex India Ltd | Listed polyester/nylon filament yarn producer | Historical supplier; direct-sales competitor | — |
| 7 | Indo Rama Synthetics (India) Ltd | Listed polyester producer | Historical supplier; direct-sales competitor | — |
| 8 | Reliance Industries (polyester business) | Integrated polyester yarn producer | Largest Indian polyester yarn supplier; sells via distributors/directly | Not segment-comparable |
| 9 | Garden Silk Mills | Surat polyester yarn producer | Historical supplier | — |
| 10 | Unlisted Surat yarn traders and mill-authorised dealers | Private | Primary day-to-day competition for customers and dealership allocations | — |
“—” = not publicly disclosed.
Peer Comparison FY2026
| Metric | Anand Rayons | Nitin Spinners | Sangam (India) | Ganesha Ecosphere | AYM Syntex |
|---|---|---|---|---|---|
Market cap (INR Cr) | 79 | 3,358 | 3,158 | 2,736 | 1,712 |
Revenue TTM (INR Cr) | 453 | 3,296 | 3,305 | 1,568 | 1,390 |
Net profit TTM (INR Cr) | 10.87 | 211.83 | 121.50 | 56.60 | 18.77 |
Net margin (%) | 2.39 | 6.42 | 3.67 | 3.57 | 1.34 |
RoE (%) | 10.94 | 14.92 | 12.05 | 4.45 | 3.23 |
P/E (x) | 7.24 | 15.85 | 25.99 | 48.43 | 91.24 |
P/B (x) | 0.76 | 2.17 | 2.83 | 2.10 | 2.90 |
R&D intensity (% of revenue) | 0 disclosed | — | — | — | — |
Recent Developments
At some point the stock was placed under BSE's Additional Surveillance Measure (Long-Term ASM Stage I) per Sharpely; the date is not confirmed, and by January 2026 Choice India showed the stock under "no framework".



